Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences’ Frontiers in Cancer Immunotherapy Symposium

June 26, 2026
By Ethan Parker

Breast cancer vaccine presentation includes final Phase 1 data showing all major primary endpoints were met and protocol-defined immune responses in 74% of participantsOvarian cancer CAR-T therapy, lira-cel, presentation highlights positive survival observations from ongoing Phase 1 clinical…

Read the full release →

News provided by PR Newswire.

Must read

All Posts
Art Community
Art Exhibitions and Features
Art Exhibitions Features
Art History
Art Work
Artistic Journeys
Artwork
Community Well-Being
Design Inspiration
Press Releases
Uncategory

Think Outside the Cup for 7-Eleven, Inc.'s Bring Your Own Cup Day

Think Outside the Cup for 7-Eleven,…

September 10, 2026

The Salvation Army Marks 25 Years Since 9/11 With Stories of Service and a Call to 'Be That Something'

The Salvation Army Marks 25 Years…

September 8, 2026

Lemonade CFO to Participate in Upcoming…

September 8, 2026

Genesis wins AFR Sustainability Leaders 2026…

September 8, 2026

China Merchants Bank Wins CNCF End…

September 8, 2026

Cell Stem Cell: tBE-mediated Base Editing…

September 8, 2026